Homology Medicines, Inc. (FIXX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16
	10-K	10-K	10-K	10-K	10-K	10-K	S-1/A
Revenues	3.2	34.0	2.7	1.7	5.3	0.0	5,695.0
Revenue growth	-90.6%	1157.3%	62.2%	-68.7%		-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	10,000.0
Gross profit	3.2	34.0	2.7	1.7	5.3	0.0	-4,305.0
Gross margin	100.0%	100.0%	100.0%	100.0%	100.0%		-75.6%
Selling, general and administrative [+]	136.5	129.9	133.0	22.2	17.3	8.3	4,305.0
General and administrative				22.2	17.3	8.3	4,305.0
Research and development				89.4	47.9	21.4
Other operating expenses	-131.2						1,390.0
EBITDA [+]				-103.6	-58.6	-29.0
EBITDA growth	-97.9%	-26.3%	25.7%	76.7%	102.4%	-99.7%
EBITDA margin	-63.3%	-282.4%	-4821.0%	-6220.0%	-1101.8%		-175.6%
Depreciation and amortization				6.3	1.3	0.7
EBIT [+]	-2.0	-95.9	-130.3	-109.9	-59.9	-29.7	-10,000.0
EBIT growth	-97.9%	-26.3%	18.5%	83.5%	102.1%	-99.7%
EBIT margin	-63.3%	-282.4%	-4821.0%	-6599.2%	-1126.0%		-175.6%
Interest income	3.2	0.2	1.6	6.0	4.3	0.5
Interest income	3.2	0.2	1.6	6.0	4.3	0.5
Other income (expense), net						-0.9	10,000.0
Pre-tax income	1.2	-95.8	-128.7	-103.9	-55.6	-30.0	0.0
Income taxes	0.7	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	59.7%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-5.0	-95.8	-128.7	-103.9	-55.6	-30.0	0.0
Net margin	-156.0%	-281.9%	-4762.9%	-6237.5%	-1044.3%		0.0%

Basic EPS [+]	($0.09)	($1.73)	($2.80)	($2.47)	($1.95)	($12.10)	$0.00
Growth	-95.0%	-38.2%	13.6%	26.8%	-83.9%
Diluted EPS [+]	($0.09)	($1.73)	($2.80)	($2.47)	($1.95)	($12.10)	$0.00
Growth	-95.0%	-38.2%	13.6%	26.8%	-83.9%

Shares outstanding (basic) [+]	57.4	55.3	45.9	42.1	28.6	2.5	1,900.5
Growth	3.8%	20.4%	9.0%	47.5%	1051.5%	-99.9%
Shares outstanding (diluted) [+]	57.4	55.3	45.9	42.1	28.6	2.5	1,900.5
Growth	3.8%	20.4%	9.0%	47.5%	1051.5%	-99.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.